One of the key findings of the past decade was a discovery of a gain-of-function mutation in the podocytic transient receptor potential canonical channel 6 (TRPC6), which was found to cause Focal Segmental Glomerulosclerosis (FSGS)2–4. Here, TRPC6 is linked to focal segmental glomerulosclerosis.